What Heron Capital does

Heron Capital is a privately held investment firm founded in 2002 and headquartered in Indianapolis, Indiana. The firm is structured as a permanent-capital vehicle, funded entirely by its own principals rather than external limited partners, and explicitly markets itself as one that "invests in companies we intend to keep." All investment decisions are made by two principals — Greg Maurer (Executive Chairman & Co-Owner) and Kevin Etzkorn (Managing Director & Co-Owner) — without an investment committee or fund-level exit pressure.

Heron targets the lower middle market, focusing on companies with EBITDA up to $4M (including underperformers with a clear improvement path), with a stated thematic interest in life sciences and healthcare. Its disclosed portfolio company is Arcamed, a precision contract manufacturer of medical device cases, trays, and screw caddies serving orthopedic OEMs. Etzkorn serves as Co-founder and CFO of Arcamed, illustrating the firm's operating-partnership model.

The go-to-market is relationship-driven: principals engage business owners directly, often years before any LOI, bypassing investment bankers and formal processes. There is no external fund, no fee structure disclosure, and no intermediated distribution. Revenue is generated solely through the firm's equity ownership in operating companies, with no management fees, fund-related carry, or third-party capital arrangements. The firm has 1–10 employees, two decision-makers, and no public financial disclosures.

Name

Heron Capital

Legal name

Heron Capital Equity Partners, LLC

Website

https://heroncap.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

Heron Capital is a privately funded Indianapolis-based investment firm using permanent principal capital to acquire and operate lower middle market companies, primarily in life sciences and healthcare, with disclosed portfolio company Arcamed serving orthopedic OEMs.

Ownership category

akta.pro rank

Product category

Private Equity Investment

NAICS

Other Financial Investment Activities (5239)

SIC

Investors, Nec (6799)

akta.pro primary industry

Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE)

Keywords

• Private equity investing
• Lower middle market
• Healthcare investments
• Permanent capital
• Life sciences ventures

Headquarters

HQ city

Carmel

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Investment Returns: Heron Capital generates returns through equity ownership in portfolio companies. As a permanent capital provider funded by its own principals, the firm does not have external fund obligations or forced exit timelines, allowing it to hold investments indefinitely and focus on long-term value creation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Heron Capital is a private investment firm that deploys permanent capital into lower middle market companies, primarily in healthcare, medical devices, and life sciences. The firm is funded by its own principals rather than external limited partners, enabling indefinite investment holding with no forced exit timelines, and provides operational partnership and add-on acquisition support to portfolio companies.

Product overview

Heron Capital is a private investment firm that deploys capital into healthcare technology and services companies. As an investment firm, Heron Capital does not operate a product or software platform; instead, it acquires and invests in operating companies such as Arcamed, a precision contract manufacturer of medical device cases, trays, and screw caddies. Heron Capital has no proprietary product lines or technology offerings of its own.

Differentiator

Problem solved

Functional benefit

Products and services

• Permanent Capital Investment
• Operational Partnership Support
• Add-on Acquisition Support

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cressey & Company: Lower middle market healthcare-focused private equity firm based in Chicago. Comparable because it invests across healthcare services, medical devices, and life sciences for companies of similar size profile, often partnering with management teams for long-term value creation.
• Shore Capital Partners: Chicago-based lower middle market private equity firm with a microcap focus and significant healthcare exposure. Comparable because it partners with founder-owned businesses in the same EBITDA range, often in healthcare services and specialty manufacturing.
• Huron Capital: Detroit-based private equity firm focused on lower middle market companies. Comparable because it invests in profitable, founder-owned businesses in similar EBITDA ranges, often via partnership-oriented models in healthcare, industrials, and business services.
• Telegraph Hill Partners: San Francisco-based private equity firm focused on commercial-stage medical device, healthcare, and life sciences companies. Comparable because it partners with management teams building lower middle market healthcare businesses, including specialty manufacturing and medical technology.
• Latticework Capital Partners: Healthcare-focused private equity firm investing in lower middle market companies. Comparable because it partners with founder-led healthcare businesses across services, products, and distribution with an operating-partner orientation similar to Heron's.
• Petra Capital Partners: Nashville-based private equity firm investing growth capital in lower middle market healthcare and tech-enabled services companies. Comparable because it targets founder-owned businesses of similar size and emphasizes operational partnership over financial engineering.
• CID Capital: Indianapolis-based private investment firm that previously employed Kevin Etzkorn as a Principal. Directly comparable because of its lower middle market, healthcare/medtech orientation and its Indianapolis/Midwest base, and because its prior exits include EKOS, Renal Solutions, and Atlantis Components.
• Waud Capital Partners: Chicago-based private equity firm investing in lower middle market healthcare, business services, and specialty industrials. Comparable because it partners with management teams at companies of similar size and shares Heron's Midwest operating base and relationship-driven sourcing.
• Health Velocity Capital: Healthcare growth equity firm partnering with commercial-stage companies in healthcare services, medical devices, and digital health. Comparable because of its healthcare specialization and lower middle market orientation, though it typically invests via institutional fund capital rather than permanent principal capital.

Broad incumbents

• HealthCare Royalty Partners: Healthcare-focused investment firm with a broader, more institutional platform than Heron. Comparable thematically as a healthcare specialist that invests from proprietary/permanent capital, though it operates at a larger scale and across a wider set of healthcare structures.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heron Capital